CorMedix Inc. ( CRMD) - Stock Earnings
CRMD Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
CRMD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 14.0 million USD | 128.6 million USD |
| 2026Q1 | 38.6 million USD | 127.4 million USD |
| 2026Q2 | 26.0 million USD | 101.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CRMD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -46.3 million USD | 29702 USD |
| 2024 | -17.9 million USD | 43.5 million USD |
| 2025 | 163.1 million USD | 311.7 million USD |
| 2026 Est. | — | — |
CRMD
Price: $7.46
Earnings Per Share: 2.32 USD
P/E Ratio: 3.52
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 278900
Market Capitalization: 564.1 million